Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
SCHEDULE OF ESTIMATED FAIR VALUE OF WARRANTS  
The Company calculated the estimated fair value of warrants on the date of issuance and at each subsequent reporting date using the following assumptions:
 
 
 
For the Three Months
Ended March 31, 2023
 
 
For the Three Months
Ended March 31, 202
2
 
At December 31, 2022
 
Risk-free interest rate
 
 
3.81% - 4.06%
 
 
1.94% - 2.44%
 
 
4.06% - 4.32%
 
Contractual term
 
 
2.25 – 4.25 years
 
 
4.25 – 5 years
 
 
1.75 – 4.75 years
 
Dividend yield
 
 
0%
 
 
0%
 
 
0%
 
Expected volatility
 
 
131.94% - 143.61%
 
 
88%
 
 
88%-99.5%
 
Schedule of Earnings Per Share
The Company computes net loss per share in accordance with ASC 260, “
Earnings per Share
.
”
ASC 260 requires presentation of both basic and diluted net earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of warrants, convertible preferred stock and convertible debentures. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.
 
 
 
Three Months Ended
 
 
 
March 31,
 
 
 
2023
 
 
2022
 
Net loss computation of basic and diluted net loss per common share:
 
 
 
 
 
 
 
 
Net  loss attributable to common stockholders
 
$
(8,275,162
)
 
 
$
(12,103,938
)
 
 
 
 
 
 
 
 
 
Basic and diluted net loss per share:
 
 
 
 
 
 
 
 
Basic net loss per common share
 
$
(0.56
)
 
 
$
(14.04
)
Basic weighted average common shares outstanding
 
 
14,720,268
 
 
 
861,997
 
Schedule of Warrants Liabilities Measured at Fair Value Using Significant Unobservable Inputs
The table below provides a reconciliation of the balances for the warrant and preferred investment option liability which is measured at fair value using significant unobservable inputs (Level 3): 
 
Balance, January 1, 2022
 
$
4,801,929
 
Fair Value of warrant and preferred investment option liability at issuance
 
 
2,646,135
 
Change in fair value of warrant and preferred investment option liability
 
 
(3,616,160
)
Balance, March 31, 2022
 
$
3,831,904
 
 
Balance, January 1, 2023
 
$
16,116,273
 
Change in fair value of warrant and preferred investment option liability
 
 
(7,484,960
)
Balance, March 31, 2023
 
$
8,631,313
 
Schedule of Potential Dilutive Securities
Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows as of March 31, (in common equivalent shares):
 
 
 
March 31,
 
 
 
2023
 
 
2022
 
Warrants and preferred investment options
 
 
11,624,523
 
 
 
416,832
 
Options and restricted stock units
 
 
1,351,271
 
 
 
1,354
 
Total anti-dilutive weighted average shares
 
 
12,975,794
 
 
 
418,186